The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The hypothalamic-pituitary-adrenal axis is activated in response to stress. One of the activated hypothalamic hormones is arginine vasopressin, a hormone involved in hemodynamics and osmoregulation. Copeptin, the C-terminal part of the arginine vasopressin precursor peptide, is a sensitive and stable surrogate marker for arginine vasopressin release. Measurement of copeptin levels has been shown to be useful in a variety of clinical scenarios, particularly as a prognostic marker in patients with acute diseases such as lower respiratory tract infection, heart disease and stroke. The measurement of copeptin levels may provide crucial information for risk stratification in a variety of clinical situations. As such, the emergency department appears to be the ideal setting for its potential use. This review summarizes the recent progress towards determining the prognostic and diagnostic value of copeptin in the emergency department.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aminzadeh, F., & Dalziel, W. B. (2002) · Annals of Emergency Medicine · doi:10.1067/mem.2002.121523 · Cited by 1,119 · cited 1×
“Older patients in the ED are at risk of adverse health outcomes [39].”
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965 · cited 1×
“Corticotropin-releasing hormone and AVP appear to have a synergistic effect, resulting in adrenocorticotropic hormone (ACTH) and cortisol release [4-7].”
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor
Land, H., Schütz, G., Schmale, H., & Richter, D. (1982) · Nature · doi:10.1038/295299a0 · Cited by 569 · cited 1×
“Copeptin, a peptide of 39 amino acids, is the C-terminal part of pro-AVP and is released together with AVP during processing of the precursor peptide (see Figure 1) [3].”
Rivier, C., & Vale, W. (1983) · Nature · doi:10.1038/305325a0 · Cited by 539
Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
Reichlin, T., Hochholzer, W., Stelzig, C., Laule, K., Freidank, H., Morgenthaler, N. G., Bergmann, A., Potocki, M., Noveanu, M., Breidthardt, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.076 · Cited by 434
Self-citationVoors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp098 · Cited by 222 · cited 1×
“In a multicenter study, it was confirmed that copeptin is a strong marker for mortality and morbidity in patients with heart failure after an acute MI [25].”
Cited by
S South Yorkshire Hospitals Research Collaboration, Bateman, R. M., Sharpe, M. D., Jagger, J. E., Ellis, C. G., Solé-Violán, J., López-Rodríguez, M., Herrera-Ramos, E., Ruíz-Hernández, J., Borderías, L., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1208-6 · Cited by 526
Metadata
- Authors
- Nickel, C. H., Bingisser, R., & Morgenthaler, N. G.
- Venue
- BMC Medicine
- Published
- 2012-01-20
- Volume
- 10
- Issue
- 1
- Pages
- 7-7
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W2059324403
- Cited by
- 169
- References
- 6
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. https://app.cochat.ai/papers/10.1186/1741-7015-10-7
- The paper
- Nickel, C. H., Bingisser, R., & Morgenthaler, N. G. (2012). The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Medicine. https://doi.org/10.1186/1741-7015-10-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.